CompletedPhase 3NCT02644941
Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis
Studying Complication in hemodialysis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Humacyte, Inc.
- Principal Investigator
- Shamik Parikh, MDHumacyte, Inc.
- Intervention
- Human Acellular Vessel (HAV)(biological)
- Enrollment
- 355 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2023
Study locations (30)
- Arizona Kidney Disease and Hypertension Center (AKDHC), Phoenix, Arizona, United States
- Carondelet St. Mary's Hospital, Tucson, Arizona, United States
- Ladenheim Dialysis Access Center, Fresno, California, United States
- General Surgery and Vascular Access, Fresno, California, United States
- University of California Irvine (UCI) Medical Center, Irvine, California, United States
- VA Long Beach Healthcare System, Long Beach, California, United States
- VA Sacramento Medical Center, Mather, California, United States
- Balboa Nephrology, San Diego, California, United States
- University of South Florida, Tampa, Florida, United States
- Southwest Vascular Access Center, Alsip, Illinois, United States
- University of Maryland Medical Center, Baltimore, Maryland, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Michigan Cardiovascular Institute, Flint, Michigan, United States
- Greenwood Leflore Hospital, Greenwood, Mississippi, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
CTI Clinical Trial and Consulting Services · California Institute for Regenerative Medicine (CIRM)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02644941 on ClinicalTrials.govOther trials for Complication in hemodialysis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07438925Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure VariationCentral Hospital, Nancy, France
- RECRUITINGNANCT06341452Comparison of Individualized Sodium Management Versus Standard Treatment in HemodialysisFresenius Medical Care Deutschland GmbH
- RECRUITINGNANCT07512895The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treatment: A Randomized Controlled TrialIstanbul Aydın University
- RECRUITINGNANCT07269379Intradialytic Exercise With Blood Flow Restriction in Hemodialysis PatientsUniversity of Avignon
- ACTIVE NOT RECRUITINGNCT07412834Safely Disconnect From the Dialysis Machine in an Emergency SituationIstanbul University
- RECRUITINGPHASE1NCT07217886A Study of S-892216-PO in Participants With Renal Impairment and Matched ControlsShionogi
- RECRUITINGNANCT06978127Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis PatientsUniversity of Pittsburgh
- ACTIVE NOT RECRUITINGPHASE3NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisAkebia Therapeutics